Carolina Liquid Chemistries (CLC) offers urine fentanyl screening solutions from the point-of-care to clinical laboratories in settings such as hospitals, emergency departments, addiction clinics, and more. The Fentanyl Urine Detection Test on CLC’s next-generation, portable RYAN immunofluorescent analyzer is an FDA cleared and CLIA categorized, moderately complex, point-of-care system for detecting the fentanyl active parent compound, qualitatively in human urine at a cutoff concentration of 1.0 ng/mL. The test can be run in fewer than 6 minutes, produces a chartable result, and is interfaceable.